Senescence marker activin A is increased in human diabetic kidney disease: association with kidney function and potential implications for therapy

Senescence marker activin A is increased in human diabetic kidney disease: association with kidney function and potential implications for therapy

Objective Activin A, an inflammatory mediator implicated in cellular senescence-induced adipose tissue dysfunction and profibrotic kidney injury, may become a new target for the treatment of diabetic kidney disease (DKD) and chronic kidney diseases. We tested the hypothesis that human DKD-related in...

Full description

Saved in:
Bibliographic Details
Main Authors: Hui Tang, Lilach O Lerman, Xiaohui Bian, Tomás P Griffin, Xiangyang Zhu, Md Nahidul Islam, Sabena M Conley, Alfonso Eirin, Paula M O’Shea, Allyson K Palmer, Sandra M Herrmann, Ramila A Mehta, John R Woollard, Andrew D Rule, James L Kirkland, Tamar Tchkonia, Stephen C Textor, Matthew D Griffin, LaTonya J Hickson
Format: Article
Language:English
Published: BMJ Publishing Group 2019-05-01
Series:BMJ Open Diabetes Research & Care
Online Access:https://drc.bmj.com/content/7/1/e000720.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://drc.bmj.com/content/7/1/e000720.full

Similar Items